Yubo International Biotech Limited

Equities

YBGJ

US9883661004

Biotechnology & Medical Research

Market Closed - OTC Markets 03:45:24 2024-04-26 pm EDT 5-day change 1st Jan Change
0.21 USD -77.89% Intraday chart for Yubo International Biotech Limited -77.89% -30.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Yubo International Biotech Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Yubo International Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Yubo International Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Yubo International Biotech Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Yubo International Biotech Limited Auditor Raises 'Going Concern' Doubt CI
Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Insider Sell: Yubo International Biotech MT
Yubo International Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Yubo International Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Yubo International Biotech Limited Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Yubo International Biotech Limited Auditor Raises 'Going Concern' Doubt CI
Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Yubo International Biotech Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Yubo International Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Yubo International Biotech Limited Changes Fiscal Year End from the Last Calendar Day of February to December 31 CI
Platinum International Biotech Co., Ltd acquired Yubo International Biotech Limited for approximately $380 million in a reverse merger transaction. CI
Chart Yubo International Biotech Limited
More charts
Yubo International Biotech Ltd, formerly Magna-Lab Inc, is a holding company primarily operating through its subsidiary. The Company focuses on the research and development and application of endometrial stem cells and offers its products and services under the brand VIVCELL. The Company’s product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. The Company also offers stem cell related services including cell testing and health management consulting services.
More about the company